Lupin Limited has informed the Exchange regarding the receipt of Establishment Inspection Report (EIR) by the Company from the U.S. FDA for its injectables facility in Nagpur, India, vide Press Release dated December 16, 2025. |SUBJECT: Press Release
Markets
About Us
Contact Us
- 333, Pali Pathar, Khar West, Mumbai, Maharashtra 400052
- Pjazza Mifsud Bonnici, Marsascala, Malta
- info@markettrade.live
- +919769768500
